Penn Medicine The 7th Alfred P. Fishman Symposium: New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025

Introduction

The Penn Medicine 7th Alfred P. Fishman Symposium 2025 is an advanced pulmonary vascular disease conference focused on the latest scientific discoveries, translational research, and evidence-based management strategies for pulmonary hypertension and pulmonary embolism. Hosted by Penn Medicine, this symposium highlights major advances in pulmonary vascular biology, risk stratification, evolving treatment paradigms, and novel therapeutic approaches aimed at improving patient outcomes.

This expert-led educational program combines cutting-edge research, multidisciplinary clinical perspectives, and practical management strategies for clinicians caring for patients with pulmonary hypertension, pulmonary embolism, and complex pulmonary vascular disorders.

The curriculum integrates:

• Pulmonary hypertension
• Pulmonary embolism
• Pulmonary vascular disease
• Right heart failure
• Lung transplantation
• Risk stratification
• Pulmonary vascular physiology
• Advanced pulmonary therapeutics
• Translational pulmonary research
• Critical care pulmonology

into a comprehensive educational experience focused on modern pulmonary vascular medicine.

Course Overview

📚 Program: The 7th Alfred P. Fishman Symposium: New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025

🏛️ Presented by Penn Medicine

📅 Course Dates: April 11–12, 2025

📍 Location:
The Rubenstein Auditorium at the Smilow Center for Translational Research, Philadelphia, Pennsylvania

🎥 Included Content

• 18 video lectures
• 17 PDF presentations

💾 Course Size: 6.83 GB

🎓 Educational Format

• Expert-led lectures
• Translational research presentations
• Pulmonary vascular disease reviews
• Clinical management discussions
• Evidence-based treatment updates

The symposium delivers advanced education focused on modern pulmonary hypertension and pulmonary embolism care.

Educational Focus

The program focuses on:

• Pulmonary hypertension management
• Pulmonary embolism treatment
• Pulmonary vascular pathobiology
• Right ventricular dysfunction
• Risk stratification strategies
• Lung transplantation referral
• Novel pulmonary therapeutics
• Translational pulmonary research
• Critical care pulmonary medicine
• Emerging pulmonary vascular therapies

The curriculum emphasizes evidence-based clinical practice and evolving therapeutic paradigms in pulmonary vascular disease.

Learning Objectives

After completing this activity, learners strengthen their ability to:

• Review how recent scientific discoveries in pulmonary hypertension improve patient outcomes
• Differentiate the major types of pulmonary hypertension and select appropriate therapies for each subtype
• Apply modern risk stratification approaches in pulmonary vascular disease management
• Identify optimal timing for advanced therapies and lung transplantation referral
• Implement current standards of care for pulmonary embolism treatment and follow-up
• Discuss novel and alternative approaches to pulmonary hypertension clinical trial design
• Integrate translational pulmonary vascular research into clinical practice
• Improve multidisciplinary management of complex pulmonary vascular disorders

The educational content combines foundational science, clinical application, and advanced pulmonary vascular medicine.

Pulmonary Hypertension Management

A major component of the symposium focuses on contemporary pulmonary hypertension evaluation and treatment.

Covered Areas

• Classification of pulmonary hypertension
• Pulmonary arterial hypertension (PAH)
• Right ventricular dysfunction
• Risk stratification models
• Advanced vasodilator therapies
• Evidence-based treatment pathways

The curriculum reviews modern diagnostic and therapeutic strategies for pulmonary hypertension management.

Pulmonary Embolism & Follow-Up Care

Dedicated sessions explore evolving standards in pulmonary embolism treatment.

Topics Include

• Acute pulmonary embolism management
• Chronic thromboembolic pulmonary hypertension (CTEPH)
• Post-PE follow-up strategies
• Anticoagulation management
• Pulmonary vascular complications
• Multidisciplinary PE care models

Participants strengthen practical approaches to pulmonary embolism evaluation and long-term management.

Translational Pulmonary Vascular Research

The symposium emphasizes the integration of research discoveries into patient care.

Educational Topics

• Pulmonary vascular pathobiology
• Translational science applications
• Novel therapeutic targets
• Emerging pulmonary vascular therapies
• Clinical trial innovation
• Precision medicine approaches

The sessions highlight how scientific discoveries are reshaping pulmonary vascular disease management.

Lung Transplantation & Advanced Therapies

Specialized educational sessions review advanced treatment pathways for severe pulmonary vascular disease.

Covered Areas

• Referral for lung transplantation
• Advanced pulmonary hypertension therapies
• End-stage pulmonary vascular disease
• Multidisciplinary transplant evaluation
• Patient selection strategies
• Long-term management considerations

The curriculum emphasizes timely referral and advanced care planning.

Risk Stratification & Patient Outcomes

A central educational theme involves improving outcomes through individualized risk assessment.

Topics Include

• Risk stratification models
• Prognostic assessment tools
• Treatment escalation strategies
• Functional status evaluation
• Hemodynamic monitoring
• Outcome-focused management

Participants gain practical skills for tailoring therapy based on patient-specific risk profiles.

Interactive Clinical Learning

The symposium incorporates clinically relevant and research-focused educational experiences.

Included Features

• Expert faculty presentations
• Pulmonary vascular case discussions
• Emerging therapy reviews
• Translational medicine sessions
• Evidence-based guideline updates
• Multidisciplinary clinical perspectives

The interactive format strengthens both clinical reasoning and advanced pulmonary vascular knowledge.

Educational Experience

The course combines:

• Pulmonary hypertension education
• Pulmonary embolism management
• Pulmonary vascular medicine
• Critical care pulmonology
• Translational pulmonary research
• Advanced therapeutics
• Lung transplantation review
• Evidence-based pulmonary medicine

The educational structure emphasizes state-of-the-art pulmonary vascular disease management and modern therapeutic advances.

Why This Course Stands Out

Advanced Pulmonary Vascular Focus

Provides specialized education dedicated to pulmonary hypertension and pulmonary embolism.

Translational Research Integration

Bridges scientific discovery with practical patient-centered clinical care.

Evidence-Based Therapeutic Updates

Highlights modern treatment strategies and evolving pulmonary vascular guidelines.

Multidisciplinary Clinical Perspective

Combines expertise from pulmonology, cardiology, critical care, and transplant medicine.

Focus on Patient Outcomes

Emphasizes individualized therapy, risk stratification, and long-term management strategies.

Clinical Value

The Penn Medicine 7th Alfred P. Fishman Symposium 2025 delivers advanced pulmonary vascular education through integrated coverage of:

• Pulmonary hypertension
• Pulmonary embolism
• Pulmonary vascular disease
• Pulmonary arterial hypertension
• Right heart dysfunction
• Lung transplantation
• Risk stratification
• Translational pulmonary research
• Advanced pulmonary therapeutics
• Critical care pulmonology
• Pulmonary vascular physiology
• Evidence-based pulmonary medicine

The combination of expert-led instruction, cutting-edge research, advanced therapeutic review, and multidisciplinary clinical education makes this symposium highly valuable for clinicians seeking state-of-the-art education in pulmonary vascular disease management.

 Topics:

• BPA.mp4
  BPA.pdf
  Comorbidities, Inclusion Criteria, and Treatment Effects – More or Less.pdf
  Connect the Tissue Disease Dots in Pulmonary Hypertension.mp4
  Connect the Tissue Disease Dots in Pulmonary Hypertension.pdf
  Data Safety and Monitoring in PAH.mp4
  Data Safety and Monitoring in PAH.pdf
  Hospitalized patient with PAH or IPAH- The Lung Phenotype.mp4
  Hospitalized patient with PAH or IPAH- The Lung Phenotype.pdf
  Magic 8-Ball Says the Patient Has HFpEF PH.mp4
  Magic 8-Ball Says the Patient Has HFpEF PH.pdf
  Minimizing Health Care-Research Contact Days- No place like home.mp4
  Minimizing Health Care-Research Contact Days- No place like home.pdf
  PE(nn) Wars- Debate.mp4
  PE(nn) Wars- Debate.pdf
  People Living with Pulmonary Arterial Hypertension – In Their Own Words.mp4
  Recruiting Minority Members into PH Clinical Trials-Why and how-.mp4
  Recruiting Minority Members into PH Clinical Trials-Why and how-.pdf
  Sex Healing in PAH.mp4
  Sex Healing in PAH.pdf
  Slow Metabolism- The Right Ventricle in Pulmonary Hypertension.mp4
  Slow Metabolism- The Right Ventricle in Pulmonary Hypertension.pdf
  Talking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.mp4
  Talking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.pdf
  The Science Leading to Sotatercept and Beyond.mp4
  The Science Leading to Sotatercept and Beyond.pdf
  To Transplant, or not to Transplant.mp4
  To Transplant, or not to Transplant.pdf
  Treatment of ILD-PH – When to Hold `em and When to Fold `em.mp4
  Treatment of ILD-PH – When to Hold `em and When to Fold `em.pdf
  Welcome & Introduction.mp4
  What’s the (End) Point-.mp4
  What’s the (End) Point-.pdf
  WSPH Treatment Algo in Pulmonary Hypertension.mp4
  WSPH Treatment Algo in Pulmonary Hypertension.pdf